Skip to main content
. 2023 Jul 22;27:73. doi: 10.1186/s40824-023-00405-7

Fig. 11.

Fig. 11

Antibacterial sonodynamic nanoplatforms. A HMMP nanovaccine for the treatment of osteomyelitis. Model 1: nanovaccines activate explosive antigen release, prompting APC priming and eliciting immunoantimicrobial therapy under US stimulation; Model 2: nanovaccines can activate systemic immunological reactions to remove the bacteria; Model 3: nanovaccines confer recipient with immune memory for combating bacterial rechallenge [97]. Copyright©2022, American Chemical Society. B Schematic illustration of US-responsive catalytic MBs for treating chronic lung infections [98]. Copyright©2023, Xiu et al. American Association for the Advancement of Science